| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| IF1-H5223 | Human | Human IFN-gamma R1 / IFNGR1 Protein, His Tag |  |
|
|
| IF1-H5254 | Human | Human IFN-gamma R1 / IFNGR1 Protein, Fc Tag |  |
|
Immobilized Human IFN-gamma, premium grade (Cat. No. IFG-H4211) at 5 μg/mL (100 μL/well) can bind Human IFN-gamma R1, Fc Tag (Cat. No. IF1-H5254) with a linear range of 1-10 ng/mL (QC tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Interferon gamma biosimilar (Recpharma) | Approved | Recpharma | IMMUNEX | Osteoporosis; Neoplasms; Virus Diseases; Granulomatous Disease, Chronic | Details | |||||
| Recombinant interferon gamma (Shanghai Chemo Wanbang Biopharma) | Approved | Shanghai Chemo Wanbang Biophama Co Ltd | 伽玛, gamma | Mainland China | Granulomatous Disease, Chronic | Shanghai Chemo Wanbang Biophama Co Ltd | 1998-01-01 | Arthritis, Rheumatoid; Liver Cirrhosis; Granulomatous Disease, Chronic | Details | |
| Interferon gamma-1a biosimilar (Shionogi) | S-6810 | Approved | Shionogi & Co Ltd | Imunomax-γ | Japan | Communicable Diseases; Mycosis Fungoides; Carcinoma, Renal Cell; Myocardial Infarction | Shionogi & Co Ltd | 1989-09-29 | Communicable Diseases; Carcinoma, Renal Cell; Myocardial Infarction; Mycosis Fungoides | Details |
| Interferon gamma biosimilar (Pharmaclon) | Approved | Pharmaclon | Ingaron | Russian Federation | Neoplasms; Respiratory Distress Syndrome, Newborn; Prostatitis; Chlamydia Infections; Tuberculosis, Pulmonary; Influenza, Human; HIV Infections; Hepatitis B; Herpes Zoster; Warts; Hepatitis C | Pharmaclon | 2011-01-01 | HIV Infections; RNA Virus Infections; Warts; Papillomavirus Infections; Neoplasms; Tuberculosis, Pulmonary; Chlamydia Infections; Influenza, Human; Hepatitis B; Prostatitis; Hepatitis C; Lentivirus Infections; Condylomata Acuminata; Respiratory Distress Syndrome, Newborn; Herpes Zoster | Details | |
| Interferon biosimilar (LG Life Sciences) | Approved | Lg Life Sciences Ltd | Leukemia | Lg Life Sciences Ltd | 1989-01-01 | Leukemia | Details | |||
| Interferon Gamma (Materia Medica Holding) | Approved | Materia Medica Holding Research And Production Company | Anaferon | Virus Diseases; Bacterial Infections | Details | |||||
| Interferon gamma-1a (Asubio Pharma) | SUN-4800 | Approved | Asubio | Biogamma | Japan | Mycosis Fungoides | Asubio | 1992-01-01 | Mycosis Fungoides | Details |
| Interferon gamma biosimilar (Center for Genetic Engineering and Biotechnology) | Approved | Center For Genetic Engineering And Biotechnology | Idiopathic Pulmonary Fibrosis; Tuberculosis | Details | ||||||
| Interferon gamma (Hayashibara) | OH-6000 | Approved | Hayashibara | Ogamma | Japan | Skin Neoplasms | null | 1997-08-05 | Skin Neoplasms | Details |
| Interferon gamma biosimilar (Livzon Pharmaceutical Group) | Approved | Livzon Pharmaceutical Group Inc | Mainland China | Arthritis, Rheumatoid | Livzon Pharmaceutical Group Inc | 1998-01-01 | Arthritis, Rheumatoid | Details | ||
| Interferon gamma-1b | DasKloster-1001; DasKloster-1001-01 | Approved | Genentech Inc | Immukin, Imukin 1, Actimmune | United States | Communicable Diseases | Vidara Therapeutics Research Ltd | 1999-02-25 | Candidemia; Hepatitis C, Chronic; Macular Degeneration; Melanoma; Mycobacterium avium-intracellulare Infection; Retinal Degeneration; Uveitis; Granulomatous Disease, Chronic; Adenocarcinoma, Mucinous; Uveitis, Anterior; Pulmonary Aspergillosis; Osteopetrosis; Tuberculosis, Pulmonary; Psoriasis; Aspergillosis; Cystic Fibrosis; Retinal Diseases; Friedreich Ataxia; Pulmonary Fibrosis; Lung Diseases; Idiopathic Pulmonary Fibrosis; Colonic Neoplasms; Liver Cirrhosis; Fibrosis; Communicable Diseases; Eye Diseases, Hereditary; Pneumonia; Rectal Neoplasms; HIV Infections; Respiratory Tract Infections | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Interferon gamma (aerosol, IPF/ COPD), Stony Brook University School of Medicine | Phase 2 Clinical | Nostrum, Stony Brook University School Of Medicine, Nyu Langone Medical Center | Pulmonary Disease, Chronic Obstructive | Details | |
| rSIFN-co | Phase 3 Clinical | Sichuan Huiyang Life Science and Technology Corp | Carcinoma, Renal Cell; Hepatitis B, Chronic; Colonic Neoplasms; Coronavirus Disease 2019 (COVID-19); Neuroendocrine Tumors; Prostatic Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
FLAG
Star Staining
ViruStop
Aneuro
ComboX
ActiveMax
GENPower
ClinMax 
Star Ribbon 
